These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10750293)

  • 21. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of switching with oral contraceptives.
    Wassef SA; Sami G; Hamid EA
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Contraception for the diabetic woman].
    Arlot S; Mesmacque A; Lalau JD; Quichaud J
    Fertil Contracept Sex; 1988 Nov; 16(11):921-6. PubMed ID: 12282829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacology of different progestogens: the special case of drospirenone.
    Sitruk-Ware R
    Climacteric; 2005 Oct; 8 Suppl 3():4-12. PubMed ID: 16203650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oral contraception: evolution of concepts over the last thirty years].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11 Suppl):1-8. PubMed ID: 12281408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of newer progestins for contraception.
    Sitruk-Ware R; Nath A
    Contraception; 2010 Nov; 82(5):410-7. PubMed ID: 20933114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proceedings: Hormonal contraceptives and sex hormone-binding globulin capacity.
    Thijssen JH
    J Endocrinol; 1975 Mar; 64(3):50P-51P. PubMed ID: 166132
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of ovulation by gestagens.
    Johansson E; Larsson-Cohn U; Nygren KG; Jeppsson S; Victor A; Weiner E
    Ups J Med Sci Suppl; 1978; 22():16-22. PubMed ID: 274856
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral contraceptives.
    Maclennan AH
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.
    El-Ibiary SY; Cocohoba JM
    Eur J Contracept Reprod Health Care; 2008 Jun; 13(2):123-32. PubMed ID: 18465473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception.
    Africander D; Verhoog N; Hapgood JP
    Steroids; 2011 Jun; 76(7):636-52. PubMed ID: 21414337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Veins and contraception].
    Reinharez D; Monsonego J
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):131-6. PubMed ID: 12280199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new estradiol-dienogest oral contraceptive marks "The Pill's" 50th anniversary.
    Keder LM
    Am J Ther; 2011 Jan; 18(1):38-44. PubMed ID: 21192241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormonal contraceptives and venous thromboembolism: an epidemiological update.
    Plu-Bureau G; Maitrot-Mantelet L; Hugon-Rodin J; Canonico M
    Best Pract Res Clin Endocrinol Metab; 2013 Feb; 27(1):25-34. PubMed ID: 23384743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J; Gompel A; Plu-Bureau G
    Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins.
    Bradley DD; Wingerd J; Petitti DB; Krauss RM; Ramcharan S
    N Engl J Med; 1978 Jul; 299(1):17-20. PubMed ID: 207983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic characteristics of progestins used for contraception and hormone replacement therapy, including new transdermal technologies.
    Burkman RT
    Am J Manag Care; 2001 Nov; 7(18 Suppl):S571-4. PubMed ID: 11727395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oral contraceptives and thromboembolism (author's transl)].
    Sato K; Ogino M; Nakabayashi M; Sakamoto S
    Kokyu To Junkan; 1978 Mar; 26(3):212-20. PubMed ID: 349637
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.